Ascendis Pharma A/S (Ascendis Pharma A/S) Institutional Ownership : 84.56% (As of Apr. 27, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ascendis Pharma A/S's institutional ownership is 84.56%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ascendis Pharma A/S's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ascendis Pharma A/S's Float Percentage Of Total Shares Outstanding is 69.40%.

Ascendis Pharma A/S Institutional Ownership Historical Data

The historical data trend for Ascendis Pharma A/S's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Institutional Ownership Chart

Ascendis Pharma A/S Historical Data

The historical data trend for Ascendis Pharma A/S can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	72.66	72.70	72.23	71.60	72.11	72.09	87.32	87.06	86.99	84.56

Ascendis Pharma A/S Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.